Benzinga's Top Initiations - Adient (NYSE:ADNT), Amgen (NASDAQ:AMGN)

Analysts at Mizuho initiated coverage on Biogen Inc BIIB with a Neutral rating. The price target for Biogen is set to $290. Biogen shares closed at $295.62 on Monday.
Jefferies initiated coverage on BioScrip Inc BIOS with a Buy rating. BioScrip shares closed at $2.61 on Monday.
Analysts at Piper Jaffray initiated coverage of Mammoth Energy Services Inc TUSK with an Overweight rating. Mammoth Energy shares closed at $13.61 on Monday.
Analysts at JP Morgan initiated coverage of Adient PLC ADNT with a Neutral rating. The price target for Adient is set to $55. Adient shares closed at $44.60 on Monday.
Analysts at Aegis Capital initiated coverage on Nektar Therapeutics NKTR with a Buy rating. The price target for Nektar Therapeutics is set to $21. Nektar Therapeutics shares closed at $12.80 on Monday.
Mizuho initiated coverage on Amgen, Inc. AMGN with a Buy rating. The price target for Amgen is set to $164. Amgen shares closed at $139.21 on Monday.
Analysts at Deutsche Bank initiated coverage on Microsemi Corporation MSCC with a Buy rating. The price target for Microsemi is set to $60. Microsemi shares closed at $47.84 on Monday.
Analysts at Imperial Capital initiated coverage on Newcastle Investment Corp. NCT with an In-Line rating. The price target for Newcastle Investment is set to $4.50. Newcastle Investment shares closed at $4.54 on Monday.
Analysts at BMO Capital initiated coverage on Sociedad Quimica y Minera de Chile (ADR) SQM with a Market Perform rating. The price target for Sociedad Quimica y Minera de Chile is set to $30. Sociedad Quimica y Minera de Chile shares closed at $29.07 on Monday.
Mizuho initiated coverage on Celgene Corporation CELG with a Buy rating. The price target for Celgene is set to $130. Celgene shares closed at $107.49 on Monday.

Market News and Data brought to you by Benzinga APIs